Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Nuvo-Group, Ltd.
PregSense™ is a maternal-fetal monitor that non-invasively measures and displays fetal heart rate, maternal hear rate and uterine contractions. This study will be performed to collect and digitally record data from PregSense™ and the standard of care (CTG) in order to provide evidence of safety and agreement between PregSense™ and the gold standard NST device.
Age
18–50
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
Female age between 18-50
Gestational age \> 32 + 0 weeks
Singleton gestation
Ability to understand and sign informed consent
You may not be if
BMI (Body Mass Index) ≥ 45 and ≤15 prior pregnancy
Multiple gestation
Uncontrolled Hypertension
Fetal Anomaly
Subjects with skin problems in the abdominal area (such as flesh wounds, cuts in the skin, skin rashes, etc.)
Subjects with implanted electronic devices (pacemaker, defibrillator, etc.)
Subjects who, in the judgement of the investigator, are likely to be non-compliant or uncooperative during the study